Hester Biosciences informs about outcome of resolution

27 Mar 2023 Evaluate
Hester Biosciences has informed that the Board of Directors by circulation of resolution, have approved the resolutions listed into the outcome as attached. The second term of Naman Patel and Amit Shukla, as independent directors, will be completed by the end of the day of 31 March 2023. Therefore, from 1 April 2023, both directors will cease to be directors of the Company. The shareholders' approval will be taken for said resolutions through postal ballot and postal ballot notice to be submitted to the exchange separately. The details required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, are mentioned in Annexure attached.

The above information is a part of company’s filings submitted to BSE 

Hester Biosciences Share Price

2380.05 9.90 (0.42%)
23-Dec-2024 15:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1814.85
Dr. Reddys Lab 1342.00
Cipla 1476.25
Lupin 2156.45
Zydus Lifesciences 971.35
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.